JP6108498B2 - 分子分析物の特性の最適な測定のための波長を選択する方法および装置 - Google Patents
分子分析物の特性の最適な測定のための波長を選択する方法および装置 Download PDFInfo
- Publication number
- JP6108498B2 JP6108498B2 JP2015510359A JP2015510359A JP6108498B2 JP 6108498 B2 JP6108498 B2 JP 6108498B2 JP 2015510359 A JP2015510359 A JP 2015510359A JP 2015510359 A JP2015510359 A JP 2015510359A JP 6108498 B2 JP6108498 B2 JP 6108498B2
- Authority
- JP
- Japan
- Prior art keywords
- sample
- wavelength
- operating
- spectral
- equation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000000034 method Methods 0.000 title claims description 68
- 238000005259 measurement Methods 0.000 title claims description 46
- 239000012491 analyte Substances 0.000 title description 30
- 230000003595 spectral effect Effects 0.000 claims description 66
- 239000000126 substance Substances 0.000 claims description 48
- 230000003287 optical effect Effects 0.000 claims description 44
- 238000004422 calculation algorithm Methods 0.000 claims description 40
- 108010054147 Hemoglobins Proteins 0.000 claims description 37
- 102000001554 Hemoglobins Human genes 0.000 claims description 37
- 210000004369 blood Anatomy 0.000 claims description 35
- 239000008280 blood Substances 0.000 claims description 35
- 239000011159 matrix material Substances 0.000 claims description 30
- 239000000463 material Substances 0.000 claims description 28
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 27
- 229910052760 oxygen Inorganic materials 0.000 claims description 27
- 239000001301 oxygen Substances 0.000 claims description 27
- 230000001419 dependent effect Effects 0.000 claims description 26
- 238000010521 absorption reaction Methods 0.000 claims description 23
- 238000001228 spectrum Methods 0.000 claims description 20
- 239000006185 dispersion Substances 0.000 claims description 18
- 238000005457 optimization Methods 0.000 claims description 17
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims description 16
- 230000005670 electromagnetic radiation Effects 0.000 claims description 16
- 238000004519 manufacturing process Methods 0.000 claims description 15
- 239000007789 gas Substances 0.000 claims description 14
- 238000002922 simulated annealing Methods 0.000 claims description 14
- 230000008033 biological extinction Effects 0.000 claims description 13
- 102000004169 proteins and genes Human genes 0.000 claims description 13
- 108090000623 proteins and genes Proteins 0.000 claims description 13
- 150000002632 lipids Chemical class 0.000 claims description 12
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 11
- 239000008103 glucose Substances 0.000 claims description 11
- 238000001514 detection method Methods 0.000 claims description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- 229910001868 water Inorganic materials 0.000 claims description 10
- UGFAIRIUMAVXCW-UHFFFAOYSA-N Carbon monoxide Chemical compound [O+]#[C-] UGFAIRIUMAVXCW-UHFFFAOYSA-N 0.000 claims description 9
- 229910002091 carbon monoxide Inorganic materials 0.000 claims description 9
- 239000001569 carbon dioxide Substances 0.000 claims description 8
- 229910002092 carbon dioxide Inorganic materials 0.000 claims description 8
- 238000012545 processing Methods 0.000 claims description 7
- 238000011002 quantification Methods 0.000 claims description 7
- 230000004044 response Effects 0.000 claims description 7
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 4
- 230000031700 light absorption Effects 0.000 claims description 4
- 238000013016 damping Methods 0.000 claims 1
- VUZPPFZMUPKLLV-UHFFFAOYSA-N methane;hydrate Chemical compound C.O VUZPPFZMUPKLLV-UHFFFAOYSA-N 0.000 claims 1
- 239000000523 sample Substances 0.000 description 74
- 230000006870 function Effects 0.000 description 38
- 238000009826 distribution Methods 0.000 description 17
- 230000003321 amplification Effects 0.000 description 13
- 230000003993 interaction Effects 0.000 description 13
- 238000003199 nucleic acid amplification method Methods 0.000 description 13
- 238000002496 oximetry Methods 0.000 description 12
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 10
- 230000008859 change Effects 0.000 description 10
- 230000008569 process Effects 0.000 description 10
- 238000002106 pulse oximetry Methods 0.000 description 10
- 230000035945 sensitivity Effects 0.000 description 9
- INGWEZCOABYORO-UHFFFAOYSA-N 2-(furan-2-yl)-7-methyl-1h-1,8-naphthyridin-4-one Chemical compound N=1C2=NC(C)=CC=C2C(O)=CC=1C1=CC=CO1 INGWEZCOABYORO-UHFFFAOYSA-N 0.000 description 8
- 238000013459 approach Methods 0.000 description 8
- 108010061951 Methemoglobin Proteins 0.000 description 7
- 108010064719 Oxyhemoglobins Proteins 0.000 description 7
- 230000002526 effect on cardiovascular system Effects 0.000 description 7
- 238000011156 evaluation Methods 0.000 description 7
- 230000002159 abnormal effect Effects 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 230000002829 reductive effect Effects 0.000 description 6
- 238000004364 calculation method Methods 0.000 description 5
- 230000000747 cardiac effect Effects 0.000 description 5
- 108010002255 deoxyhemoglobin Proteins 0.000 description 5
- 238000010586 diagram Methods 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 238000004611 spectroscopical analysis Methods 0.000 description 5
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- 230000005540 biological transmission Effects 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 238000009792 diffusion process Methods 0.000 description 4
- 238000012544 monitoring process Methods 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 230000001154 acute effect Effects 0.000 description 3
- 210000002565 arteriole Anatomy 0.000 description 3
- 230000015556 catabolic process Effects 0.000 description 3
- 238000004891 communication Methods 0.000 description 3
- 238000004590 computer program Methods 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 230000001902 propagating effect Effects 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 235000000346 sugar Nutrition 0.000 description 3
- 230000007704 transition Effects 0.000 description 3
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 230000002238 attenuated effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 230000007211 cardiovascular event Effects 0.000 description 2
- 238000012790 confirmation Methods 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 238000009795 derivation Methods 0.000 description 2
- 230000006866 deterioration Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 239000000975 dye Substances 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 150000003278 haem Chemical class 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 230000033001 locomotion Effects 0.000 description 2
- 230000000541 pulsatile effect Effects 0.000 description 2
- 230000010349 pulsation Effects 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- 239000004065 semiconductor Substances 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- 230000008733 trauma Effects 0.000 description 2
- KXRMREPJUITWDU-UHFFFAOYSA-N 2-amino-4,6-dimethyl-3-oxophenoxazine-1,9-dicarboxylic acid Chemical compound N1=C2C(C(O)=O)=C(N)C(=O)C(C)=C2OC2=C1C(C(O)=O)=CC=C2C KXRMREPJUITWDU-UHFFFAOYSA-N 0.000 description 1
- 108010044267 Abnormal Hemoglobins Proteins 0.000 description 1
- 238000012935 Averaging Methods 0.000 description 1
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- 102000017011 Glycated Hemoglobin A Human genes 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 238000000342 Monte Carlo simulation Methods 0.000 description 1
- QRSFFHRCBYCWBS-UHFFFAOYSA-N [O].[O] Chemical compound [O].[O] QRSFFHRCBYCWBS-UHFFFAOYSA-N 0.000 description 1
- 238000000862 absorption spectrum Methods 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 238000000149 argon plasma sintering Methods 0.000 description 1
- 230000008321 arterial blood flow Effects 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 210000000476 body water Anatomy 0.000 description 1
- UBAZGMLMVVQSCD-UHFFFAOYSA-N carbon dioxide;molecular oxygen Chemical compound O=O.O=C=O UBAZGMLMVVQSCD-UHFFFAOYSA-N 0.000 description 1
- 230000002612 cardiopulmonary effect Effects 0.000 description 1
- -1 chromophores Substances 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 239000007857 degradation product Substances 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 108010076316 dyshemoglobins Proteins 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 238000012854 evaluation process Methods 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 108091005995 glycated hemoglobin Proteins 0.000 description 1
- 238000011478 gradient descent method Methods 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000013307 optical fiber Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 238000001441 oximetry spectrum Methods 0.000 description 1
- 230000036284 oxygen consumption Effects 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 230000000644 propagated effect Effects 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000004043 responsiveness Effects 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000004088 simulation Methods 0.000 description 1
- 238000010583 slow cooling Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/25—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
- G01N21/31—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry
- G01N21/314—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry with comparison of measurements at specific and non-specific wavelengths
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
- A61B5/0075—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence by spectroscopy, i.e. measuring spectra, e.g. Raman spectroscopy, infrared absorption spectroscopy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14539—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring pH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14546—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring analytes not otherwise provided for, e.g. ions, cytochromes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
- A61B5/14551—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters for measuring blood gases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/1495—Calibrating or testing of in-vivo probes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01J—MEASUREMENT OF INTENSITY, VELOCITY, SPECTRAL CONTENT, POLARISATION, PHASE OR PULSE CHARACTERISTICS OF INFRARED, VISIBLE OR ULTRAVIOLET LIGHT; COLORIMETRY; RADIATION PYROMETRY
- G01J3/00—Spectrometry; Spectrophotometry; Monochromators; Measuring colours
- G01J3/02—Details
- G01J3/10—Arrangements of light sources specially adapted for spectrometry or colorimetry
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01J—MEASUREMENT OF INTENSITY, VELOCITY, SPECTRAL CONTENT, POLARISATION, PHASE OR PULSE CHARACTERISTICS OF INFRARED, VISIBLE OR ULTRAVIOLET LIGHT; COLORIMETRY; RADIATION PYROMETRY
- G01J3/00—Spectrometry; Spectrophotometry; Monochromators; Measuring colours
- G01J3/12—Generating the spectrum; Monochromators
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/25—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
- G01N21/27—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands using photo-electric detection ; circuits for computing concentration
- G01N21/274—Calibration, base line adjustment, drift correction
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/47—Scattering, i.e. diffuse reflection
- G01N21/4738—Diffuse reflection, e.g. also for testing fluids, fibrous materials
- G01N21/474—Details of optical heads therefor, e.g. using optical fibres
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/47—Scattering, i.e. diffuse reflection
- G01N21/49—Scattering, i.e. diffuse reflection within a body or fluid
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
- G01N33/49—Blood
- G01N33/4925—Blood measuring blood gas content, e.g. O2, CO2, HCO3
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01J—MEASUREMENT OF INTENSITY, VELOCITY, SPECTRAL CONTENT, POLARISATION, PHASE OR PULSE CHARACTERISTICS OF INFRARED, VISIBLE OR ULTRAVIOLET LIGHT; COLORIMETRY; RADIATION PYROMETRY
- G01J3/00—Spectrometry; Spectrophotometry; Monochromators; Measuring colours
- G01J3/02—Details
- G01J3/10—Arrangements of light sources specially adapted for spectrometry or colorimetry
- G01J2003/102—Plural sources
- G01J2003/104—Monochromatic plural sources
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/25—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
- G01N21/31—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry
- G01N21/314—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry with comparison of measurements at specific and non-specific wavelengths
- G01N2021/3144—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry with comparison of measurements at specific and non-specific wavelengths for oxymetry
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/21—Polarisation-affecting properties
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/25—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
- G01N21/31—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry
- G01N21/35—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry using infrared light
- G01N21/3504—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry using infrared light for analysing gases, e.g. multi-gas analysis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2201/00—Features of devices classified in G01N21/00
- G01N2201/06—Illumination; Optics
- G01N2201/061—Sources
- G01N2201/06113—Coherent sources; lasers
Landscapes
- Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pathology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Surgery (AREA)
- Veterinary Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- General Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Theoretical Computer Science (AREA)
- Mathematical Physics (AREA)
- Ecology (AREA)
- Urology & Nephrology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
- Investigating Or Analysing Materials By Optical Means (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261640682P | 2012-04-30 | 2012-04-30 | |
| US61/640,682 | 2012-04-30 | ||
| US201361789565P | 2013-03-15 | 2013-03-15 | |
| US61/789,565 | 2013-03-15 | ||
| PCT/US2013/038621 WO2013165887A1 (en) | 2012-04-30 | 2013-04-29 | Method and apparatus for selecting wavelengths for optimal measurement of a property of a molecular analyte |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015519556A JP2015519556A (ja) | 2015-07-09 |
| JP2015519556A5 JP2015519556A5 (de) | 2015-08-20 |
| JP6108498B2 true JP6108498B2 (ja) | 2017-04-05 |
Family
ID=48325956
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015510359A Active JP6108498B2 (ja) | 2012-04-30 | 2013-04-29 | 分子分析物の特性の最適な測定のための波長を選択する方法および装置 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US9714900B2 (de) |
| EP (1) | EP2844980A1 (de) |
| JP (1) | JP6108498B2 (de) |
| WO (1) | WO2013165887A1 (de) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012178064A2 (en) | 2011-06-23 | 2012-12-27 | Mayo Foundation For Medical Education And Research | System and method for detecting vascular contamination by surgical anesthetic using non-invasive ir spectrophotometry |
| US9377396B2 (en) | 2011-11-03 | 2016-06-28 | Verifood, Ltd. | Low-cost spectrometry system for end-user food analysis |
| EP3028020B1 (de) | 2013-08-02 | 2021-11-24 | Verifood Ltd. | Spektrometriesystem |
| WO2015101992A2 (en) | 2014-01-03 | 2015-07-09 | Verifood, Ltd. | Spectrometry systems, methods, and applications |
| WO2016063284A2 (en) | 2014-10-23 | 2016-04-28 | Verifood, Ltd. | Accessories for handheld spectrometer |
| WO2016105248A1 (ru) * | 2014-12-22 | 2016-06-30 | Эдвард Владимирович КРЫЖАНОВСКИЙ | Способ неинвазивного определения концентрации глюкозы в крови |
| WO2016125164A2 (en) | 2015-02-05 | 2016-08-11 | Verifood, Ltd. | Spectrometry system applications |
| WO2016125165A2 (en) | 2015-02-05 | 2016-08-11 | Verifood, Ltd. | Spectrometry system with visible aiming beam |
| WO2016162865A1 (en) | 2015-04-07 | 2016-10-13 | Verifood, Ltd. | Detector for spectrometry system |
| US10066990B2 (en) | 2015-07-09 | 2018-09-04 | Verifood, Ltd. | Spatially variable filter systems and methods |
| US10203246B2 (en) | 2015-11-20 | 2019-02-12 | Verifood, Ltd. | Systems and methods for calibration of a handheld spectrometer |
| US10254215B2 (en) | 2016-04-07 | 2019-04-09 | Verifood, Ltd. | Spectrometry system applications |
| US20200337600A1 (en) * | 2016-06-28 | 2020-10-29 | Christopher Slawinski | Sample position resolved noninvasive glucose concentration determination analyzer apparatus and method of use thereof |
| EP3488204A4 (de) | 2016-07-20 | 2020-07-22 | Verifood Ltd. | Zubehör für handhaltbares spektrometer |
| US10791933B2 (en) | 2016-07-27 | 2020-10-06 | Verifood, Ltd. | Spectrometry systems, methods, and applications |
| JP6847627B2 (ja) * | 2016-10-27 | 2021-03-24 | 日本光電工業株式会社 | 医用フォトメータ、および医用フォトメータの制御方法 |
| CN110411947B (zh) * | 2018-04-28 | 2022-07-22 | 天津大学 | 时间门定光程参考测量浓度的方法及装置 |
| US11473976B2 (en) | 2018-10-08 | 2022-10-18 | Mayo Foundation For Medical Education And Research | Spectrophotometer system and enhanced optical characterization of biological samples using same |
| EP3936035A4 (de) * | 2019-03-06 | 2022-05-11 | Asahi Kasei Kabushiki Kaisha | Vorrichtung zur messung biologischer informationen |
| JP7299726B2 (ja) * | 2019-03-20 | 2023-06-28 | キヤノン株式会社 | 肌の色の測定装置及びプログラム |
| KR20200119501A (ko) * | 2019-04-10 | 2020-10-20 | 삼성전자주식회사 | 생체정보 추정 장치 및 방법 |
| US11654635B2 (en) | 2019-04-18 | 2023-05-23 | The Research Foundation For Suny | Enhanced non-destructive testing in directed energy material processing |
| US11678819B2 (en) * | 2019-04-24 | 2023-06-20 | Roxanne Abul-Haj | Noninvasive applied force / optical glucose concentration determination analyzer apparatus and method of use thereof |
| AU2020275745A1 (en) * | 2019-05-12 | 2021-12-09 | Quantum Innovation Australia Pty Ltd | Blood analysis devices, systems and methods |
| US11131584B2 (en) * | 2019-08-01 | 2021-09-28 | Viavi Solutions Inc. | Sensor device |
| CA3195149A1 (en) * | 2020-10-24 | 2022-04-28 | Spectronix Inc. | Optical device, system and method for monitoring blood-borne chromophores |
| CN113588585A (zh) * | 2021-06-25 | 2021-11-02 | 张玉芝 | 一种用于复合气体组分的快速检测方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5435309A (en) * | 1993-08-10 | 1995-07-25 | Thomas; Edward V. | Systematic wavelength selection for improved multivariate spectral analysis |
| US6253097B1 (en) * | 1996-03-06 | 2001-06-26 | Datex-Ohmeda, Inc. | Noninvasive medical monitoring instrument using surface emitting laser devices |
| US7097973B1 (en) * | 1999-06-14 | 2006-08-29 | Alpha Mos | Method for monitoring molecular species within a medium |
| WO2005041771A1 (ja) * | 2003-11-04 | 2005-05-12 | Hitachi, Ltd. | 生体光計測装置 |
| US8423116B2 (en) * | 2005-03-16 | 2013-04-16 | Or-Nim Medical Ltd. | Noninvasive measurements in a human body |
| EP1996910A2 (de) * | 2006-02-22 | 2008-12-03 | Vivum Nexus LLC | Vorrichtung und verfahren für analytmessungen |
| JP5721959B2 (ja) * | 2010-03-16 | 2015-05-20 | オリンパス株式会社 | 蛍光内視鏡装置 |
-
2013
- 2013-04-29 WO PCT/US2013/038621 patent/WO2013165887A1/en active Application Filing
- 2013-04-29 JP JP2015510359A patent/JP6108498B2/ja active Active
- 2013-04-29 EP EP13721242.9A patent/EP2844980A1/de not_active Withdrawn
- 2013-04-29 US US14/397,810 patent/US9714900B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US9714900B2 (en) | 2017-07-25 |
| EP2844980A1 (de) | 2015-03-11 |
| WO2013165887A1 (en) | 2013-11-07 |
| JP2015519556A (ja) | 2015-07-09 |
| US20150119661A1 (en) | 2015-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6108498B2 (ja) | 分子分析物の特性の最適な測定のための波長を選択する方法および装置 | |
| US10260947B2 (en) | Spectrometric systems and methods for improved focus localization of time- and space-varying measurements | |
| US8706178B2 (en) | Method and device for determining oxygen saturation of hemoglobin, for determining hematocrit of blood, and/or for detecting macular degeneration | |
| US9222832B2 (en) | Device and method for detecting and monitoring ingredients or properties of a measurement medium, in particular of physiological blood values | |
| JP5186044B2 (ja) | 血糖値推定装置 | |
| US8412296B2 (en) | Non-invasive determination of the concentration of a blood substance | |
| US20040033618A1 (en) | Accommodating subject and instrument variations in spectroscopic determinations | |
| JP2015519556A5 (de) | ||
| JP2007509718A5 (de) | ||
| US20080200780A1 (en) | Optical measurement of cellular energetics | |
| JP2010005047A (ja) | 光学式生体成分測定用の検量モデルの作成方法及び非侵襲血糖値測定装置 | |
| JP4329360B2 (ja) | グルコース濃度の定量装置 | |
| CN109313115A (zh) | 全血so2传感器 | |
| US9357955B2 (en) | Portable analytical device and system | |
| Parab et al. | Blood glucose prediction using machine learning on jetson nanoplatform | |
| KR102511907B1 (ko) | 광학 모듈을 이용한 비침습적 생체물질 당농도 측정 시스템 및 방법 | |
| RU2793540C1 (ru) | Портативное устройство и способ для неинвазивного измерения элементов крови | |
| Castro-Pimentel et al. | Three-wavelength PPG and support vector machine for non-invasive estimation of blood glucose | |
| RU2517155C1 (ru) | Способ определения концентраций производных гемоглобина в биологических тканях | |
| NAGAO et al. | Value Estimation of SpO2 Using a Non-Contact Method | |
| US20040162468A1 (en) | Absolute oxygen saturation for monitoring tissue viability | |
| Pandozzi | Spectroscopic analysis of fractal scattering and hidden layers in complex scattering samples | |
| Cysewska-Sobusiak | Living tissue as the optical pulsatile cuvette contributing to arrangement of the measuring system | |
| Bronzino | Optical Sensors | |
| Cysewska-Sobusiak | Optoelectronic blood oximetry as a tool of health safety monitoring |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20150624 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20160428 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20170131 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20170207 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20170301 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20170302 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 6108498 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |